$TIKK
TEL INSTRUMENT ELECTRONICS CORP Stock $tikk

$tikk Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000118518524000659 Filed on June 28, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2024
Revenue	$2.842M	$1.974M	$8.809M
YoY Change	-0.86%	-3.07%	2.06%
Cost Of Revenue	$2.096M	$578.8K	$4.792M
YoY Change	33.32%	-54.43%	-14.16%
Gross Profit	$745.9K	$1.395M	$4.017M
YoY Change	-42.38%	82.05%	31.77%
Gross Profit Margin	26.24%	70.68%	45.6%
Selling, General & Admin	$542.3K	$594.6K	$2.115M
YoY Change	-7.27%	22.42%	0.77%
% of Gross Profit	72.71%	42.61%	52.65%
Research & Development	$131.6K	$242.1K	$1.156M
YoY Change	-54.52%	-22.34%	-36.29%
% of Gross Profit	17.65%	17.35%	28.77%
Depreciation & Amortization	$9.030K	$10.30K	$45.82K
YoY Change	-26.43%	-38.51%	-18.62%
% of Gross Profit	1.21%	0.74%	1.14%
Operating Expenses	$674.0K	$836.6K	$3.281M
YoY Change	-22.91%	4.93%	-16.88%
Operating Profit	$71.92K	$558.6K	$736.8K
YoY Change	-82.89%	-1905.4%	-182.04%
Interest Expense	-$18.45K	-$46.53K	-$244.0K
YoY Change	-58.46%	-24.01%	-155501.27%
% of Operating Profit	-25.65%	-8.33%	-33.11%
Other Income/Expense, Net	-$18.45K	$26.03K	-$217.0K
YoY Change	-58.47%	-4666.67%	-156.88%
Pretax Income	$53.48K	$528.2K	$519.8K
YoY Change	-85.77%	-560.84%	-200.61%
Income Tax	$11.23K	$180.3K	$177.9K
% Of Pretax Income	21.0%	34.13%	34.23%
Net Earnings	$42.25K	$253.5K	$341.9K
YoY Change	-85.69%	-267.96%	-187.99%
Net Earnings / Revenue	1.49%	12.84%	3.88%
Basic Earnings Per Share	-$0.02		$0.00
Diluted Earnings Per Share	-$0.02	$0.08	$0.00
COMMON SHARES
Basic Shares Outstanding	3.256M shares	3.256M shares	3.256M shares
Diluted Shares Outstanding	3.256M shares		3.256M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$149.6K	$132.0K	$132.0K
YoY Change	-96.7%	-96.56%	-96.56%
Cash & Equivalents	$149.6K	$132.0K	$132.0K
Short-Term Investments
Other Short-Term Assets	$212.8K	$214.0K	$214.0K
YoY Change	-90.51%	-90.21%	-90.21%
Inventory	$5.208M	$5.412M	$5.412M
Prepaid Expenses	$185.1K	$186.2K
Receivables	$1.764M	$1.111M	$1.111M
Other Receivables	$211.00	$211.00	$210.00
Total Short-Term Assets	$7.334M	$6.868M	$6.868M
YoY Change	-36.94%	-38.43%	-38.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$64.17K	$73.20K	$1.398M
YoY Change	-26.14%	-14.06%	-13.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$35.11K	$35.11K	$2.486M
YoY Change	0.0%	0.0%	-6.66%
Total Long-Term Assets	$3.811M	$3.883M	$3.883M
YoY Change	-8.07%	-9.15%	-9.15%
TOTAL ASSETS
Total Short-Term Assets	$7.334M	$6.868M	$6.868M
Total Long-Term Assets	$3.811M	$3.883M	$3.883M
Total Assets	$11.15M	$10.75M	$10.75M
YoY Change	-29.36%	-30.32%	-30.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.243M	$1.277M	$1.277M
YoY Change	296.81%	295.85%	295.85%
Accrued Expenses	$649.8K	$578.9K	$578.9K
YoY Change	-90.86%	266.6%	-91.68%
Deferred Revenue
YoY Change
Short-Term Debt	$1.081M	$690.0K	$690.0K
YoY Change	56.59%	0.0%	0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.031M	$2.619M	$2.619M
YoY Change	-63.11%	-67.66%	-67.66%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$43.52K	$45.50K	$1.280M
YoY Change	-15.39%	-97.07%	-17.54%
Total Long-Term Liabilities	$43.52K	$45.50K	$1.280M
YoY Change	-15.39%	-97.07%	-17.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.031M	$2.619M	$2.619M
Total Long-Term Liabilities	$43.52K	$45.50K	$1.280M
Total Liabilities	$4.248M	$3.898M	$3.898M
YoY Change	-56.19%	-59.6%	-59.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.965M	-$6.007M
YoY Change	-1.47%	-5.39%
Common Stock	$325.6K	$325.6K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.898M	$6.854M	$6.854M
YoY Change
Total Liabilities & Shareholders Equity	$11.15M	$10.75M	$10.75M
YoY Change	-29.36%	-30.32%	-30.32%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	$42.25K	$253.5K	$341.9K
YoY Change	-85.69%	-267.96%	-187.99%
Depreciation, Depletion And Amortization	$9.030K	$10.30K	$45.82K
YoY Change	-26.43%	-38.51%	-18.62%
Cash From Operating Activities	-$373.0K	-$88.78K	-$6.406M
YoY Change	-152.81%	-27.89%	278.11%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$33.85K
YoY Change	-100.0%	-100.0%	29.53%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$33.85K
YoY Change	-100.0%	-100.0%	29.53%
FINANCING ACTIVITIES
Cash Dividend Paid			$0.00
YoY Change			-100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$390.5K	0.000	$721.0K
YoY Change		-100.0%	18.2%
NET CHANGE
Cash From Operating Activities	-$373.0K	-88.78K	-$6.406M
Cash From Investing Activities	$0.00	0.000	-$33.85K
Cash From Financing Activities	$390.5K	0.000	$721.0K
Net Change In Cash	$17.54K	-88.78K	-$5.718M
YoY Change	-97.47%	-116.23%	415.06%
FREE CASH FLOW
Cash From Operating Activities	-$373.0K	-$88.78K	-$6.406M
Capital Expenditures	$0.00	$0.00	$33.85K
Free Cash Flow	-$373.0K	-$88.78K	-$6.439M
YoY Change	-153.87%	-37.96%	274.33%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Entity File Number EntityFileNumber	001-31990
CY2024	dei	Entity Registrant Name EntityRegistrantName	TEL-INSTRUMENT ELECTRONICS CORP.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NJ
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-1441806
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Branca Road
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	East Rutherford
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07073
CY2024	dei	City Area Code CityAreaCode	(201)
CY2024	dei	Local Phone Number LocalPhoneNumber	933-1600
CY2024	dei	Security12g Title Security12gTitle	Common Stock $.10 par value
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	3586188	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	3255887	shares
CY2024	dei	Auditor Firm AuditorFirmId	688
CY2024	dei	Auditor Name AuditorName	Marcum LLP
CY2024	dei	Auditor Location AuditorLocation	Marlton, New Jersey
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132013	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3839398	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1110548	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	900881	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	5411644	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3586065	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	2011083	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	214161	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	817625	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	6868366	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	11155052	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	73195	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	85167	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1324463	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1526551	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2450657	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2627935	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35109	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35109	usd
CY2024Q1	us-gaap	Assets Assets	10751790	usd
CY2023Q1	us-gaap	Assets Assets	15429814	usd
CY2024Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	690000	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	690000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	210111	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	202087	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1276935	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	322582	usd
CY2024Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	72803	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	123117	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	248713	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	240034	usd
CY2024Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	0	usd
CY2023Q1	us-gaap	Litigation Reserve Current LitigationReserveCurrent	6360698	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	120027	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	157896	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2618589	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8096414	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1114352	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1324464	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	45501	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	53416	usd
CY2024Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	119721	usd
CY2023Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	173883	usd
CY2024Q1	us-gaap	Liabilities Liabilities	3898163	usd
CY2023Q1	us-gaap	Liabilities Liabilities	9648177	usd
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.1
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	7000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	7000000	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3255887	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3255887	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3255887	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3255887	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	325586	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	325586	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6379085	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6721535	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6006958	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6348849	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6853627	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5781637	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10751790	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15429814	usd
CY2024	us-gaap	Revenues Revenues	8809087	usd
CY2023	us-gaap	Revenues Revenues	8631157	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4791734	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5582407	usd
CY2024	us-gaap	Gross Profit GrossProfit	4017353	usd
CY2023	us-gaap	Gross Profit GrossProfit	3048750	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2114945	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2098684	usd
CY2024	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	9870	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	33988	usd
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1155750	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1814198	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	3280565	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	3946870	usd
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	736788	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-898120	usd
CY2024	us-gaap	Investment Income Interest InvestmentIncomeInterest	24642	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	17188	usd
CY2024	us-gaap	Interest Expense Debt InterestExpenseDebt	70086	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	157	usd
CY2024	us-gaap	Interest Expense Other InterestExpenseOther	198535	usd
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	263425	usd
CY2024	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	27025	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	627832	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-216954	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	381438	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	519834	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-516682	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	177943	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-128137	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	341891	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-388545	usd
CY2024	us-gaap	Dividends Preferred Stock DividendsPreferredStock	351549	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	320000	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9658	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-708545	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3255887	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3255887	shares
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	6227000	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	80000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	23182	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-388545	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	5781637	usd
CY2024	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	721000	usd
CY2024	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9099	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	341891	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	6853627	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	341891	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-388545	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	177278	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-128348	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45823	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	56304	usd
CY2024	us-gaap	Other Noncash Expense OtherNoncashExpense	202088	usd
CY2023	us-gaap	Other Noncash Expense OtherNoncashExpense	194370	usd
CY2024	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-75271	usd
CY2023	us-gaap	Provision For Other Losses ProvisionForOtherLosses	-52955	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	9099	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	23182	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	209667	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-148159	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1750308	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	712613	usd
CY2024	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-603464	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	573585	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	954353	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-83907	usd
CY2024	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6360698	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	263425	usd
CY2024	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-7915	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	53416	usd
CY2024	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-104476	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-111906	usd
CY2024	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	8679	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-170504	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-202088	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-194370	usd
CY2024	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-37869	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-16249	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6405617	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1694126	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33851	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	26133	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-33851	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-26133	usd
CY2024	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	721000	usd
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2024	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2023	us-gaap	Payments Of Dividends PaymentsOfDividends	80000	usd
CY2024	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
CY2023	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	690000	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	721000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	610000	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-5718468	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1110259	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5850481	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6960740	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	132013	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5850481	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132013	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3839398	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2011083	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	132013	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5850481	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3839398	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4949690	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2011083	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2011050	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5850481	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6960740	usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet	1728593	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	157	usd
CY2024	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>1. Business, Organization, and Liquidity</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Business and Organization</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Tel-Instrument Electronics Corp. (“Tel,” “TIC,” or the “Company”) has been in business since 1947. The Company is a leading designer and manufacturer of avionics test and measurement instruments for the global, commercial air transport, general aviation, and government/military defense markets. Tel provides instruments to test, measure, calibrate, and repair a wide range of airborne navigation and communication equipment. The Company sells its equipment in both domestic and international markets. Tel continues to develop new products in anticipation of customers’ needs and to maintain its strong market position. Its development of multi-function testers has made it easier for customers to perform ramp tests with less operator training, fewer test sets, and lower product support costs. The Company has become a major manufacturer and supplier of Identification Friend or Foe (“IFF”) flight line test equipment over the last two decades.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Liquidity </b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On March 31, 2024, the Company had positive working capital of $4,249,777 as compared to working capital of $3,058,638 on March 31, 2023. The Company has approximately $132,000 of cash on hand at year-end. During September 2023, after the company losing the Aeroflex appeal, paid in full all judgements and interest of approximately $6.6 million.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On April 1, 2023, Bank of America further extended the maturity date of our line of credit from June 30, 2024 to July 31, 2024. Additionally, the line of credit available was increased from $690,000 to $1,000,000. Bank of America will begin the line of credit renewal process in the coming weeks. The Company believes it has sufficient cash on hand and expected cash flow from operations for the next twelve months due to the increase in business and the opportunities we have included in our projections. The Company’s operating profit will continue to improve, as well as our net income with the conclusion of the Aeroflex interest bearing judgment.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In September 2023, the Company raised $721,000 from the issuance of Preferred Stock. The Company entered into a definitive subscription agreement pursuant to which an accredited investor purchased 66,667 shares of the Company’s Series B Preferred Stock (the “Series B Preferred”) for $400,000. These funds were used for working capital purposes to support the orders received and expected in the near term. The Company also entered into a definitive subscription agreement pursuant to which two accredited investors purchased 53,500 shares of the Company’s Series C Preferred Stock (the “Series C Preferred”) in total for $321,000. These funds were used for working capital purposes to support the orders received and expected in the near term (one accredited investor is a member of the Board of Directors who invested $171,000 and the other accredited investor is a related party who invested $150,000).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">There was an increase in our receipt of new orders with an open order back log of $7.2 million at March 31, 2024 as compared to the Company’s backlog at March 31, 2023 was $6.5 million.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">In June 2024, the Company’s CEO provided a short term advance totaling $20,500.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based on the foregoing, we believe that our expected cash flows from operations, and fulfillment of our $7.2 million open orders will be sufficient to operate in the normal course of business for next 12 months from the issuance date of these financial statements.</p>
CY2024Q1	tikk	Working Capital WorkingCapital	4249777	usd
CY2023Q1	tikk	Working Capital WorkingCapital	3058638	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	132000	usd
CY2024	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	6600000	usd
CY2024	tikk	Backlog Backlog	7200000	usd
CY2023	tikk	Backlog Backlog	6500000	usd
CY2024	us-gaap	Extended Product Warranty Description ExtendedProductWarrantyDescription	The extended warranties sold by the Company provide a level of assurance beyond the coverage for defects that existed at the time of a sale or against certain types of covered damage with coverage terms generally ranging from 2 to 7 years.
CY2024Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	179422	usd
CY2023Q1	us-gaap	Extended Product Warranty Accrual ExtendedProductWarrantyAccrual	296400	usd
CY2024	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	122378	usd
CY2023	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	98908	usd
CY2023Q1	us-gaap	Deferred Revenue And Credits DeferredRevenueAndCredits	296400	usd
CY2024	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	5400	usd
CY2024	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	122378	usd
CY2024Q1	us-gaap	Deferred Revenue And Credits DeferredRevenueAndCredits	179422	usd
CY2024	us-gaap	Revenues Revenues	8809087	usd
CY2023	us-gaap	Revenues Revenues	8631157	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3600000	usd
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	211	usd
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	643976	usd
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Use of Estimates:</b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The most significant estimates include income taxes, inventory, and accounts receivable valuations.</p>
CY2024	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Warranty Expenses:</b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Warranty reserves are based upon historical rates and specific items that are identifiable and can be estimated at time of sale. While warranty costs have historically been within the Company’s expectations and the provisions established, future warranty costs could be in excess of the Company’s warranty reserves. A significant increase in these costs could adversely affect the Company’s operating results for the period and the periods these additional costs materialize. Warranty reserves are adjusted from time to time when actual warranty claim experience differs from estimates. For the year ended March 31, 2024, warranty reserve costs were $18,047 as compared to $17,479 for the year ended March 31, 2023, and are included in Cost of Sales in the accompanying consolidated statement of operations. See Note 10 for warranty reserves.</p>
CY2024Q1	us-gaap	Product Liability Accrual Component Amount ProductLiabilityAccrualComponentAmount	18047	usd
CY2023Q1	us-gaap	Product Liability Accrual Component Amount ProductLiabilityAccrualComponentAmount	17479	usd
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Risks and Uncertainties:</b></p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company’s operations are subject to a number of risks, including but not limited to changes in the general economy, demand for the Company’s products, the success of its customers, research and development results, reliance on the government and commercial markets, litigation, and the renewal of its line of credit. The Company has major contracts with the U.S. Government, which like all government contracts are subject to termination.</p><p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The U.S. and global markets are experiencing volatility and disruption following the escalation of geopolitical tensions and the start of the military conflict between Russia and Ukraine as well as the military conflicts in the Middle East. A continuation or worsening of the levels of market disruption and volatility seen in the recent past could have an adverse effect on our ability to access capital and on the market price of our common stock, and we may not be able to successfully raise capital through the sale of our securities.</p>
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8570	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6401	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1110548	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	900881	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	214161	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	817625	usd
CY2024Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	2835120	usd
CY2023Q1	us-gaap	Other Inventory Supplies OtherInventorySupplies	2602447	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2912737	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1388679	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	48630	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	55052	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	384843	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	460113	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	5411644	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	3586065	usd
CY2018Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	2000000	usd
CY2023Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	2011083	usd
CY2024Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	186231	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	148929	usd
CY2024Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	27719	usd
CY2023Q1	us-gaap	Deferred Costs Current DeferredCostsCurrent	24720	usd
CY2023Q1	us-gaap	Other Receivables OtherReceivables	628401	usd
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3237557	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3231981	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	73195	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	85167	usd
CY2024	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45823	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	56304	usd
CY2024Q1	us-gaap	Line Of Credit LineOfCredit	690000	usd
CY2023Q1	us-gaap	Line Of Credit LineOfCredit	690000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y5M1D
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	1830857	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	1830857	usd
CY2024Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	506394	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	304306	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1324463	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1526551	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	254840	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	267767	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	277000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	277000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	277000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	115415	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1469022	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	144559	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1324463	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	210111	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1114352	usd
CY2024	us-gaap	Operating Lease Expense OperatingLeaseExpense	400333	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	408588	usd
CY2024Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	166914	usd
CY2023Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	163430	usd
CY2024Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	81799	usd
CY2023Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	76604	usd
CY2024Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	248713	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	240034	usd
CY2024Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	0	usd
CY2023Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	19049	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	87548	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	87407	usd
CY2024Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	13756	usd
CY2023Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	40707	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18723	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10733	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	120027	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	157896	usd
CY2017Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.1
CY2017Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	250000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	111500	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.14
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M19D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3680	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	12500	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.16
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	99000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.13
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y9M10D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2024	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	0	shares
CY2024	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	99000	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.13
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y9M10D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	82200	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.16
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P0Y6M
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	49200	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.16
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P1Y6M
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2024	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y8M12D
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	9099	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	23182	usd
CY2024	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2024	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	665	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	211	usd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	665	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	211	usd
CY2024	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	146595	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-120422	usd
CY2024	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	30683	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-7926	usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	177278	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-128348	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	177943	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-128137	usd
CY2024Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1234075	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	566694	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	342218	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	329032	usd
CY2024Q1	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	53	usd
CY2023Q1	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	54	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements	1363176	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1817	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	1372	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	81609	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	98608	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	35396	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits	35025	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	18565	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	18732	usd
CY2024Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	25388	usd
CY2023Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	63651	usd
CY2024Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	16001	usd
CY2024Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	350	usd
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	354	usd
CY2024Q1	tikk	Deferred Tax Assets Liabilities Property Plant And Equipment DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment	13052	usd
CY2023Q1	tikk	Deferred Tax Assets Liabilities Property Plant And Equipment DeferredTaxAssetsLiabilitiesPropertyPlantAndEquipment	5986	usd
CY2024Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	835914	usd
CY2023Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	229250	usd
CY2024Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2588437	usd
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2727935	usd
CY2024Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	137780	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	100000	usd
CY2024Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2450657	usd
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2627935	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	177943	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-128137	usd
CY2024	us-gaap	Other Income OtherIncome	628400	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2024	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	109165	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-108503	usd
CY2024	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-170	usd
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3966	usd
CY2024	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	2335	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-126355	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	37780	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	0	usd
CY2024	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	19103	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-21942	usd
CY2024	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	9730	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	132629	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	177943	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-128137	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	341891	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-388545	usd
CY2024	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	351549	usd
CY2023	us-gaap	Other Preferred Stock Dividends And Adjustments OtherPreferredStockDividendsAndAdjustments	320000	usd
CY2024	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9658	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-708545	usd
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3255887	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3255887	shares
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2024	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2525052	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1961278	shares
CY2024	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	53324	usd
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	58090	usd
CY2024	us-gaap	Revenues Revenues	8809087	usd
CY2023	us-gaap	Revenues Revenues	8631157	usd
CY2024	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2024	us-gaap	Revenues Revenues	8809087	usd
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4791734	usd
CY2024	us-gaap	Gross Profit GrossProfit	4017353	usd
CY2024	tikk	Total Operatingand Nonoperating Expenses TotalOperatingandNonoperatingExpenses	3497519	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	519834	usd
CY2024Q1	us-gaap	Assets Assets	10751790	usd
CY2023	us-gaap	Revenues Revenues	8631157	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5582407	usd
CY2023	us-gaap	Gross Profit GrossProfit	3048750	usd
CY2023	tikk	Total Operatingand Nonoperating Expenses TotalOperatingandNonoperatingExpenses	3565432	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-516682	usd
CY2023Q1	us-gaap	Assets Assets	15429814	usd
CY2024	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	6600000	usd
CY2024	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0000096885
CY2024	dei	No Trading Symbol Flag NoTradingSymbolFlag	true

Files In Submission

Name	View Source	Status
0001185185-24-000659-index-headers.html	Edgar Link	pending
0001185185-24-000659-index.html	Edgar Link	pending
0001185185-24-000659.txt	Edgar Link	pending
0001185185-24-000659-xbrl.zip	Edgar Link	pending
ex_692076.htm	Edgar Link	pending
ex_692077.htm	Edgar Link	pending
ex_692078.htm	Edgar Link	pending
ex_692079.htm	Edgar Link	pending
ex_692080.htm	Edgar Link	pending
ex_692081.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
telinstru20240331_10k.htm	Edgar Link	pending
tikk-20240331.xsd	Edgar Link	pending
tikk-20240331_cal.xml	Edgar Link	unprocessable
tikk-20240331_def.xml	Edgar Link	unprocessable
tikk-20240331_pre.xml	Edgar Link	unprocessable
tikk-20240331_lab.xml	Edgar Link	unprocessable
telinstru20240331_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TIKK
TEL INSTRUMENT ELECTRONICS CORP Stock $tikk

2024 Q2 Form 10-K Financial Statement

#000118518524000659 Filed on June 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TIKK TEL INSTRUMENT ELECTRONICS CORP Stock $tikk

2024 Q2 Form 10-K Financial Statement

#000118518524000659 Filed on June 28, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TIKK
TEL INSTRUMENT ELECTRONICS CORP Stock $tikk